Status:
ENROLLING_BY_INVITATION
Linking Temporal Patterns of Modifiable Behaviors to Weight Loss Outcomes
Lead Sponsor:
University of Colorado, Denver
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Obesity
Weight Change, Body
Eligibility:
All Genders
18-60 years
Brief Summary
This study is designed as an observational trial. The objective of this study is to follow-up with participants 3 years after completion of an 18-month comprehensive behavioral weight loss interventio...
Detailed Description
A total of 170 participants were initially enrolled in the comprehensive behavioral weight loss intervention.In this study, investigators will conduct a follow-up visit 3 years after the completion of...
Eligibility Criteria
Inclusion
- Previous enrollment in standard behavioral weight loss intervention (NCT01985568 or NCT03411356)
- Age 20-60 (This age range has been selected based upon the participants enrolled in the Parent Trial)
- Capable and willing to give informed consent
- Possess a smartphone to install and utilize the meal timing application
- Capable and willing to wear the Actigraph, ActivPAL and Actiwatch-2 for 24 hours/day for 28 consecutive days
- Willing to complete the Total Daily Energy Expenditure (TDEE) assessment which includes multiple urine collections and drinking stable water isotopes
Exclusion
- Being considered unsafe to participate as determined by the study physician (Dr. Catennaci)
- New diagnosis of a medical condition (not observed in the Parent Trial) which may affect weight or energy metabolism (e.g. depression, CVD, diabetes, uncontrolled hypertension, untreated thyroid, renal, hepatic diseases)
- Women who became pregnant after completing the Parent Trial
- Current use or use within the last 6 months of prescription or over-the-counter medications known to affect appetite, weight, and sleep
Key Trial Info
Start Date :
January 7 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03840733
Start Date
January 7 2019
End Date
January 1 2026
Last Update
December 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States, 80045